Time to Optimize Infectious Disease Screening in Pregnancy

J Obstet Gynaecol Can. 2023 Feb;45(2):101-102. doi: 10.1016/j.jogc.2022.12.009.

Authors

Isabelle Boucoiran¹, Chelsea Elwood², Vanessa Poliquin³; SOGC Infectious Disease Committee

Affiliations

¹ Department of Obstetrics and Gynecology, Université de Montréal, Montréal, QC. Electronic address: isabelle.boucoiran@umontreal.ca.
² Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, BC.
³ Department of Obstetrics and Gynecology, University of Manitoba, Winnipeg, MB.

PMID: 36925218
DOI: 10.1016/j.jogc.2022.12.009

No abstract available

Publication types

Editorial

MeSH terms

Communicable Diseases*
Female
Humans
Infectious Disease Transmission, Vertical / prevention & control
Mass Screening
Pregnancy
Pregnancy Complications, Infectious* / diagnosis
Pregnancy Complications, Infectious* / prevention & control